- Home
- XNCR vs TCPC Comparison
XNCR vs TCPC Comparison
Compare XNCR & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- TCPC
- Stock Information
- Founded
- XNCR 1997
- TCPC 2006
- Country
- XNCR United States
- TCPC United States
- Employees
- XNCR N/A
- TCPC N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- TCPC Finance/Investors Services
- Sector
- XNCR Health Care
- TCPC Finance
- Exchange
- XNCR Nasdaq
- TCPC Nasdaq
- Market Cap
- XNCR 547.8M
- TCPC 603.8M
- IPO Year
- XNCR 2013
- TCPC 2012
- Fundamental
- Price
- XNCR $8.60
- TCPC $7.12
- Analyst Decision
- XNCR Buy
- TCPC Sell
- Analyst Count
- XNCR 10
- TCPC 2
- Target Price
- XNCR $23.33
- TCPC $6.75
- AVG Volume (30 Days)
- XNCR 700.0K
- TCPC 400.2K
- Earning Date
- XNCR 11-05-2025
- TCPC 11-05-2025
- Dividend Yield
- XNCR N/A
- TCPC 17.14%
- EPS Growth
- XNCR N/A
- TCPC N/A
- EPS
- XNCR N/A
- TCPC N/A
- Revenue
- XNCR $146,929,000.00
- TCPC $239,535,768.00
- Revenue This Year
- XNCR $22.06
- TCPC N/A
- Revenue Next Year
- XNCR N/A
- TCPC N/A
- P/E Ratio
- XNCR N/A
- TCPC N/A
- Revenue Growth
- XNCR N/A
- TCPC 3.11
- 52 Week Low
- XNCR $6.92
- TCPC $6.27
- 52 Week High
- XNCR $27.24
- TCPC $9.72
- Technical
- Relative Strength Index (RSI)
- XNCR 57.89
- TCPC 46.17
- Support Level
- XNCR $8.25
- TCPC $7.09
- Resistance Level
- XNCR $8.73
- TCPC $7.28
- Average True Range (ATR)
- XNCR 0.38
- TCPC 0.10
- MACD
- XNCR 0.07
- TCPC 0.02
- Stochastic Oscillator
- XNCR 78.76
- TCPC 36.00
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About TCPC BlackRock TCP Capital Corp.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.